Get the Stockscreener App
21.79
4.63%
-1.0949
Progyny Inc stock is traded at $21.79, with a volume of 3.61M.
It is down -4.63% in the last 24 hours and down -7.50% over the past month.
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$22.88
Open:
$26.55
24h Volume:
3.61M
Relative Volume:
2.18
Market Cap:
$1.95B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
34.58
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-5.95%
1M Performance:
-7.50%
6M Performance:
+0.18%
1Y Performance:
-37.03%
1-Day Range:
$21.59
$26.76
1-Week Range:
$21.59
$26.76
52-Week Range:
$13.39
$38.98
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
21.80 | 1.95B | 1.13B | 62.75M | 170.92M | 0.63 |
|
VEEV
Veeva Systems Inc
|
220.86 | 35.88B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
79.27 | 14.41B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
69.61 | 13.03B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.68 | 9.52B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
107.65 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
KeyBanc maintains Progyny stock Sector Weight amid strong outlook - Investing.com India
Progyny Tops EPS Forecast, Eyes Growth - The Motley Fool
Progyny projects slower revenue growth after losing Amazon - Crain's New York Business
Progyny, Inc. (NASDAQ:PGNY) Q4 2024 Earnings Call Transcript - Insider Monkey
Canaccord raises Progyny stock price target to $23, maintains hold - Investing.com India
Progyny, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025 -February 27, 2025 at 04:09 pm EST - Marketscreener.com
Progyny: Q4 Earnings Snapshot - mySA
Progyny Inc (PGNY) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
Progyny’s Balanced Outlook: Strong Performance Amidst Transition Challenges and Conservative Projections - TipRanks
Progyny, Inc. (PGNY) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire
Progyny, Inc. Reports Strong 2024 Financial Results - TipRanks
Earnings call transcript: Progyny Q4 2024 beats expectations, stock surges - Investing.com
Earnings call transcript: Progyny Q4 2024 beats expectations, stock surges By Investing.com - Investing.com UK
Progyny stock soars 16.9% on earnings beat, strong guidance By Investing.com - Investing.com Australia
Progyny stock soars 16.9% on earnings beat, strong guidance - Investing.com
Progyny, Inc. Announces Fourth Quarter 2024 Results - The Manila Times
Earnings Flash (PGNY) PROGYNY INC. Reports Q4 Adjusted EPS $0.42 -February 27, 2025 at 04:10 pm EST - Marketscreener.com
Progyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q4, Stock Jumps 14.7% - Yahoo Finance
What To Expect From Progyny’s (PGNY) Q4 Earnings - The Globe and Mail
What To Expect From Progyny Inc (PGNY) Q4 2024 Earnings - GuruFocus.com
What To Expect From Progyny’s (PGNY) Q4 Earnings By Stock Story - Investing.com Canada
172,732 Shares in Progyny, Inc. (NASDAQ:PGNY) Purchased by Acuitas Investments LLC - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Position Lifted by Baillie Gifford & Co. - MarketBeat
Jefferies lifts Progyny stock price target to $28 on positive outlook - Investing.com India
Jefferies lifts Progyny stock price target to $28 on positive outlook By Investing.com - Investing.com South Africa
Progyny price target raised to $30 from $25 at BofA - Yahoo Finance
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Progyny Insiders Placed Bullish Bets Worth US$5.24m - Simply Wall St
Progyny (PGNY) Projected to Post Earnings on Tuesday - MarketBeat
KeyBanc maintains Progyny stock Sector Weight rating - Investing.com India
Kornitzer Capital Management Inc. KS Sells 464,570 Shares of Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Progyny, Inc. (PGNY) And Encourages Shareholders to Connect - ACCESS Newswire
Progyny stock rises on expanded IVF access By Investing.com - Investing.com Australia
Progyny stock rises on expanded IVF access - Investing.com India
Is Progyny, Inc.'s (NASDAQ:PGNY) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Progyny, Inc. (PGNY) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PGNYProgyny, Inc. Latest Stock News & Market Updates - StockTitan
Progyny (NASDAQ:PGNY) Price Target Raised to $25.00 at Bank of America - MarketBeat
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report - GlobeNewswire
Progyny, Inc. Announces Date for Financial Results Reporting and Conference Call for Q4 and Full Year 2024 - Nasdaq
Earnings Alert: Progyny Sets Date for 2024 Annual ResultsKey Details for Investors - StockTitan
Breaking Down Progyny: 4 Analysts Share Their Views - Benzinga
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm - EIN News
Vanderbilt University Purchases Shares of 14,730 Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
22,001 Shares in Progyny, Inc. (NASDAQ:PGNY) Purchased by Guidance Capital Inc. - MarketBeat
Janney Montgomery Scott LLC Takes Position in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
The Play On Progyny: Don't Chase, But Watch And Wait (NASDAQ:PGNY) - Seeking Alpha
Truist Securities Adjusts Progyny Price Target to $24 From $19, Maintains Hold Rating - Marketscreener.com
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Progyny Inc Stock (PGNY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Anevski Peter | CHIEF EXECUTIVE OFFICER |
Dec 23 '24 |
Buy |
14.48 |
209,500 |
3,034,084 |
441,463 |
5.01%
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):